NeuroTrauma Sciences awards grant to University of Arizona College of Medicine – Phoenix Neurotrauma Research to conduct preclinical research on its novel neuroactive compound NTS-104 in mild traumatic brain injury (mTBI). We look forward to working with Dr. Lifshitz and his research group as we continue to advance NTS-104 into the clinic...Learn More
